| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $85.3M | +4.3% |
| SG&A Expense | $29.9M | +56.2% |
| Operating Income | -$115.2M | -14.1% |
| Interest Expense | $739K | — |
| Net Income | -$112.0M | -11.2% |
| EPS (Basic) | -$2.87 | +0.7% |
| EPS (Diluted) | -$2.87 | +0.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $249.8M | +66.0% |
| Short-term Investments | $101.7M | +169.2% |
| Current Assets | $355.2M | +83.5% |
| Total Assets | $356.6M | +82.3% |
| Current Liabilities | $19.1M | -24.1% |
| Total Liabilities | $30.0M | +13.5% |
| Stockholders' Equity | $326.6M | +93.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$92.5M | -16.1% |
| Investing Cash Flow | -$63.8M | -251.0% |
| Financing Cash Flow | $255.6M | — |